Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up.

Sévère K, Rouzier V, Anglade SB, Bertil C, Joseph P, Deroncelay A, Mabou MM, Wright PF, Guillaume FD, Pape JW.

Am J Trop Med Hyg. 2016 May 4;94(5):1136-42. doi: 10.4269/ajtmh.15-0700. Epub 2016 Feb 29.

2.

Afterword: relevance and realities of anthropological critique of epidemiology.

Barzilay EJ.

Camb Anthropol. 2014 Spring;32(1):114-120. No abstract available.

3.

Household Transmission of Vibrio cholerae in Bangladesh.

Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, Calderwood SB, Harris JB, Longini IM Jr.

PLoS Negl Trop Dis. 2014 Nov 20;8(11):e3314. doi: 10.1371/journal.pntd.0003314. eCollection 2014 Nov.

4.

Vibrio cholerae-induced inflammation in the neonatal mouse cholera model.

Bishop AL, Patimalla B, Camilli A.

Infect Immun. 2014 Jun;82(6):2434-47. doi: 10.1128/IAI.00054-14. Epub 2014 Mar 31.

5.

Cholera vaccination in urban Haiti.

Rouzier V, Severe K, Juste MA, Peck M, Perodin C, Severe P, Deschamps MM, Verdier RI, Prince S, Francois J, Cadet JR, Guillaume FD, Wright PF, Pape JW.

Am J Trop Med Hyg. 2013 Oct;89(4):671-81. doi: 10.4269/ajtmh.13-0171.

6.

No Evidence of Significant Levels of Toxigenic V. cholerae O1 in the Haitian Aquatic Environment During the 2012 Rainy Season.

Baron S, Lesne J, Moore S, Rossignol E, Rebaudet S, Gazin P, Barrais R, Magloire R, Boncy J, Piarroux R.

PLoS Curr. 2013 Sep 13;5. pii: ecurrents.outbreaks.7735b392bdcb749baf5812d2096d331e. doi: 10.1371/currents.outbreaks.7735b392bdcb749baf5812d2096d331e.

7.

Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases.

Seper A, Hosseinzadeh A, Gorkiewicz G, Lichtenegger S, Roier S, Leitner DR, Röhm M, Grutsch A, Reidl J, Urban CF, Schild S.

PLoS Pathog. 2013;9(9):e1003614. doi: 10.1371/journal.ppat.1003614. Epub 2013 Sep 5.

8.

Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen.

Leitner DR, Feichter S, Schild-Prüfert K, Rechberger GN, Reidl J, Schild S.

Infect Immun. 2013 Jul;81(7):2379-93. doi: 10.1128/IAI.01382-12. Epub 2013 Apr 29.

9.

Bacterial genomes in epidemiology--present and future.

Croucher NJ, Harris SR, Grad YH, Hanage WP.

Philos Trans R Soc Lond B Biol Sci. 2013 Feb 4;368(1614):20120202. doi: 10.1098/rstb.2012.0202. Print 2013 Mar 19. Review.

10.

Rise of the microbes.

Mahan MJ, Kubicek-Sutherland JZ, Heithoff DM.

Virulence. 2013 Apr 1;4(3):213-22. doi: 10.4161/viru.23380. Epub 2013 Jan 18. Review.

11.

The time of cholera.

Fisman DN, Laupland K.

Can J Infect Dis Med Microbiol. 2011 Spring;22(1):7-9. No abstract available.

12.

Characteristics and spectrum of disease among ill returned travelers from pre- and post-earthquake Haiti: The GeoSentinel experience.

Esposito DH, Han PV, Kozarsky PE, Walker PF, Gkrania-Klotsas E, Barnett ED, Libman M, McCarthy AE, Field V, Connor BA, Schwartz E, MacDonald S, Sotir MJ; GeoSentinel Surveillance Network.

Am J Trop Med Hyg. 2012 Jan;86(1):23-8. doi: 10.4269/ajtmh.2012.11-0430.

13.

Travel Health Alert Notices and Haiti cholera outbreak, Florida, USA, 2011.

Selent MU, McWhorter A, De Rochars VM, Myers R, Hunter DW, Brown CM, Cohen NJ, Molinari NA, Warwar K, Robbins D, Heiman KE, Newton AE, Schmitz A, Oraze MJ, Marano N.

Emerg Infect Dis. 2011 Nov;17(11):2169-71.

14.

Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.

Reveiz L, Chapman E, Ramon-Pardo P, Koehlmoos TP, Cuervo LG, Aldighieri S, Chambliss A.

PLoS One. 2011;6(11):e27060. doi: 10.1371/journal.pone.0027060. Epub 2011 Nov 15. Review.

15.

Epidemic cholera in a crowded urban environment, Port-au-Prince, Haiti.

Dunkle SE, Mba-Jonas A, Loharikar A, Fouché B, Peck M, Ayers T, Archer WR, De Rochars VM, Bender T, Moffett DB, Tappero JW, Dahourou G, Roels T, Quick R.

Emerg Infect Dis. 2011 Nov;17(11):2143-6. doi: 10.3201/eid1711.110772.

16.

Rapid development and use of a nationwide training program for cholera management, Haiti, 2010.

Tauxe RV, Lynch M, Lambert Y, Sobel J, Domerçant JW, Khan A.

Emerg Infect Dis. 2011 Nov;17(11):2094-8. doi: 10.3201/eid1711.110857.

17.

Lessons learned during public health response to cholera epidemic in Haiti and the Dominican Republic.

Tappero JW, Tauxe RV.

Emerg Infect Dis. 2011 Nov;17(11):2087-93. doi: 10.3201/eid1711.110827. Erratum in: Emerg Infect Dis. 2011 Dec;17(12):2399.

18.

Characterization of Vibrio cholerae O1 El Tor biotype variant clinical isolates from Bangladesh and Haiti, including a molecular genetic analysis of virulence genes.

Son MS, Megli CJ, Kovacikova G, Qadri F, Taylor RK.

J Clin Microbiol. 2011 Nov;49(11):3739-49. doi: 10.1128/JCM.01286-11. Epub 2011 Aug 31.

19.

Vaccination strategies for epidemic cholera in Haiti with implications for the developing world.

Chao DL, Halloran ME, Longini IM Jr.

Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7081-5. doi: 10.1073/pnas.1102149108. Epub 2011 Apr 11.

20.

Structural inferences for Cholera toxin mutations in Vibrio cholerae.

Shamini G, Ravichandran M, Sinnott JT, Somboonwit C, Sidhu HS, Shapshak P, Kangueane P.

Bioinformation. 2011 Mar 2;6(1):1-9.

Supplemental Content

Support Center